Indirect comparison between pembrolizumab and nivolumab for the treatment of non-small cell lung cancer: A meta-analysis of randomized clinical trials

Title
Indirect comparison between pembrolizumab and nivolumab for the treatment of non-small cell lung cancer: A meta-analysis of randomized clinical trials
Authors
Keywords
Pembrolizumab, Nivolumab, Non-small cell lung cancer, Adverse effects, Pneumonitis
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 49, Issue -, Pages 85-94
Publisher
Elsevier BV
Online
2017-05-30
DOI
10.1016/j.intimp.2017.05.019

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now